REGULUS THERAPEUTICS INC (RGLS)

US75915K3095 - Common Stock

2.47  +0.05 (+2.07%)

After market: 2.1082 -0.36 (-14.65%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to RGLS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.32. This target is 156.03% above the current price.
RGLS was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about RGLS.
In the previous month the buy percentage consensus was at a similar level.
RGLS was analyzed by 10 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 2.472.026.126.3211.55 - -18.22% 147.77% 156.03% 367.61%
Up and Down Grades
Date Firm Action Rating
2024-03-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-19 Canaccord Genuity Maintains Buy -> Buy
2024-03-18 Leerink Partners Initiate Outperform
2024-03-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-13 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2023-09-21 Canaccord Genuity Maintains Buy -> Buy
2023-09-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-19 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-28 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-21 HC Wainwright & Co. Maintains Buy
2022-11-08 Canaccord Genuity Initiate Buy
2021-09-02 Cantor Fitzgerald Initiate Overweight
2021-05-14 HC Wainwright & Co. Maintains Buy